PRE Prenetics Global Limited
Prenetics Global Limited (PRE) is confirmed to report earnings on August 18, 2026, before the market open. The consensus earnings estimate is a loss of $0.32 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of -2.2% since its last earnings release on June 10, 2026.
Sign in or subscribe to unlock sentiment, short interest, and technical indicators.
Whisperings™
About Prenetics Global Limited
Prenetics is a major global diagnostics and genetic testing company with the mission to bring health closer to millions of people globally and decentralize healthcare by making the three pillars — Prevention, Diagnostics and Personalized Care — comprehensive and accessible to anyone, at anytime and anywhere.
Sector
Healthcare
Industry
Biotechnology